Market News

Latest financial and economic news and analysis

Crypto Economy News Agency
1 hours agoCrypto Economy
Cryptocurrency Medium Importance Neutral
CASHCAT Jumps 120% as Robinhood Chain Hits $774 Million

CASHCAT Jumps 120% as Robinhood Chain Hits $774 Million

CASHCAT rose 120% in seven days and 22% in 24 hours, reaching $0.087, an $86 million capitalization and $9 million daily volume this week. Daily token deployments fell from 35,000 to 10,000, while CASHCAT reached 41,200 holders and kept Robinhood Chain's deepest memecoin liquidity pool overall.

Related Symbols 1
CASHCATUSD CASHCATUSD
Source: Crypto Economy
Visit Source
Comment
CoinPedia News Agency
1 hours agoCoinPedia
Cryptocurrency Medium Importance Neutral
Ethereum Price Eyes Next Rally After $60M ETF Inflows and Massive Whale Accumulation

Ethereum Price Eyes Next Rally After $60M ETF Inflows and Massive Whale Accumulation

Ethereum price is once again attracting institutional attention after another wave of ETF inflows and large whale transactions signaled growing confidence. While ETH has spent recent sessions consolidating around key support, on-chain accumulation and steady capital entering spot Ethereum ETFs suggest smart money is positioning for a potential breakout.

Related Symbols 1
Source: CoinPedia
Visit Source
Comment
Crypto Briefing News Agency
1 hours agoCrypto Briefing
Cryptocurrency Medium Importance Neutral
JPMorgan reports stalled inflows for Hyperliquid ETF amid competition

JPMorgan reports stalled inflows for Hyperliquid ETF amid competition

Increased competition and shifting market sentiment highlight the volatility and challenges in sustaining investor interest in niche ETFs. JPMorgan reports stalled inflows for Hyperliquid ETF amid competition.

Related Symbols 1
HYPEUSD HYPEUSD
Source: Crypto Briefing
Visit Source
Comment
Seeking Alpha News Agency
1 hours agoSeeking Alpha
General Medium Importance Neutral
Don't Ignore This Powerful Historical Precedent

Don't Ignore This Powerful Historical Precedent

Markets anticipate conflict resolution in the Strait of Hormuz, easing inflation fears and supporting a pause in Fed rate hikes. Tech sector valuations have normalized with the broader market due to strong Q2 earnings, reducing risk and improving sector attractiveness.

Source: Seeking Alpha
Visit Source
Comment
CNBC Television News Agency
1 hours agoCNBC Television
General Medium Importance Neutral
David Ellison needs to come up with structural remedies the state AGs will accept: Rich Greenfield

David Ellison needs to come up with structural remedies the state AGs will accept: Rich Greenfield

Rich Greenfield, LightShed Partners co-founder, joins 'Squawk Box' to discuss the state of Paramount-Warner Bros. Discovery merger, antitrust concerns, what David Ellison and Paramount can do to move forward with the proposed merger, and more.

Source: CNBC Television
Visit Source
Comment
24/7 Wall Street News Agency
1 hours ago24/7 Wall Street
Stocks Medium Importance Neutral
High Beta Runners Up: Why AMD and Marvell Technology Now Command Attention

High Beta Runners Up: Why AMD and Marvell Technology Now Command Attention

Advanced Micro Devices (NASDAQ:AMD | AMD Price Prediction) and Marvell Technology (NASDAQ:MRVL) have cleared their most recent earnings, deepening the case for treating them as the market's preferred high beta alternatives to NVIDIA (NASDAQ:NVDA) and Broadcom (NASDAQ:AVGO).

Related Symbols 1
AMD AMD
Source: 24/7 Wall Street
Visit Source
Comment
Crypto Briefing News Agency
1 hours agoCrypto Briefing
Cryptocurrency Medium Importance Neutral
Fomo surpasses Axiom Exchange for top daily Solana trading volume

Fomo surpasses Axiom Exchange for top daily Solana trading volume

Fomo's rise highlights the shifting dynamics in crypto trading, emphasizing the importance of innovation and adaptability in competitive markets. Fomo surpasses Axiom Exchange for top daily Solana trading volume.

Related Symbols 1
Source: Crypto Briefing
Visit Source
Comment
Seeking Alpha News Agency
1 hours agoSeeking Alpha
Stocks Medium Importance Neutral
ANI Pharmaceuticals: The Market Is Pricing The Present, Not The Future

ANI Pharmaceuticals: The Market Is Pricing The Present, Not The Future

ANI Pharmaceuticals is rated Buy at ~$80, with a 12-month fair value set at $95, as the current valuation undervalues 2027 earnings potential. 2026 results are depressed by upfront gout expansion costs and higher Corticotrophin royalties, but revenue and operating leverage from these investments are expected to materialize in 2027. Most 2026 Cortrophin growth is projected from established indications, not the new gout initiative, which is viewed as a 2027 upside driver.

Related Symbols 1
ANIP ANIP
Source: Seeking Alpha
Visit Source
Comment